Table 2.
Primary examined concepts for the systematic reviews.
| Primary Focus | Frequency | Percentage |
|---|---|---|
| Antimicrobial Resistance | 8 | 12.7 |
| Efficacy | 6 | 9.52 |
| Behaviour | 5 | 7.94 |
| Information technology | 5 | 7.94 |
| Economic impact | 4 | 6.35 |
| Quality | 4 | 6.35 |
| Role of Pharmacy | 4 | 6.35 |
| Critical Care | 3 | 4.76 |
| Effectiveness | 3 | 4.76 |
| Efficacy and Safety | 3 | 4.76 |
| Implementation | 3 | 4.76 |
| Adverse Events | 2 | 3.17 |
| Antimicrobial Switch | 1 | 1.59 |
| Antimicrobial consumption | 1 | 1.59 |
| Clinical and economic outcomes | 1 | 1.59 |
| Discharge medications | 1 | 1.59 |
| Emergency department | 1 | 1.59 |
| Guidelines | 1 | 1.59 |
| Healthcare Associated infections | 1 | 1.59 |
| Metrics | 1 | 1.59 |
| Microbiological outcomes | 1 | 1.59 |
| Middle- and low-income countries | 1 | 1.59 |
| National interventions | 1 | 1.59 |
| Safety | 1 | 1.59 |
| Surveillance | 1 | 1.59 |
| Total | 63 | 100% |